Skip to content

Clinical trials

Choroidal Neovascularization trials in the United Kingdom

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Choroidal Neovascularization Country / region: United Kingdom Clear all

15 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20073
20081
20091
20102
20121
20132
20191
20222
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed7
Terminated5
Active, not recruiting2
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals4
Novartis3
Pfizer2
AbbVie1
Adverum Biotechnologies, Inc.1
Allergan1
EyeBiotech Ltd.1
Ophthotech Corporation1
Quark Pharmaceuticals1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Choroidal Neovascularization15
Macular Degeneration12
Wet Macular Degeneration4
Eye Diseases3
Myopia, Degenerative2
Retinal Degeneration2
Retinal Diseases2
Blindness1
Diabetic Retinopathy1
Geographic Atrophy1

Trials

Showing 1 to 15 of 15. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.